Literature DB >> 22186872

Microbial degradation of physiologically active peptides by strain B-9.

Fumio Kondo1, Shoshiro Okada, Atsushi Miyachi, Miki Kurita, Kiyomi Tsuji, Ken-ichi Harada.   

Abstract

The reaction of some physiologically active peptides with bacterial strain B-9 has been investigated. Bradykinin, β-endorphin, and [Leu(5)]enkephalin were quickly degraded, with half-lives of <5 min. Somatostatin, substance P, and angiotensin I were degraded relatively smoothly, with half-lives of 10 min to 1 h, whereas oxytocin and insulin were slowly degraded, with half-lives of 1 and 4 days, respectively. Vasopressin was barely degraded, with a half-life of >7 days. Linearized vasopressin, prepared by the reductive cleavage of the disulfide bond followed by alkylation with iodoacetamide, was degraded significantly faster than intact vasopressin, with a half-life of 2.5 h. A loop formed by disulfide bond formation was regarded as one of the degradation-resistant factors. Hydrolysis of the peptides in this study took place through cleavage of various peptide bonds, and the strain B-9 may bear similarities to the neutral endopeptidase in terms of its broad selectivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186872     DOI: 10.1007/s00216-011-5635-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  Complete Genome Sequence of a Microcystin-Degrading Bacterium, Sphingosinicella microcystinivorans Strain B-9.

Authors:  Haiyan Jin; Tomoyasu Nishizawa; Yong Guo; Akito Nishizawa; Ho-Dong Park; Hajime Kato; Kiyomi Tsuji; Ken-Ichi Harada
Journal:  Microbiol Resour Announc       Date:  2018-09-06

2.  Microbial Degradation of Amino Acid-Containing Compounds Using the Microcystin-Degrading Bacterial Strain B-9.

Authors:  Haiyan Jin; Yoshiko Hiraoka; Yurie Okuma; Elisabete Hiromi Hashimoto; Miki Kurita; Andrea Roxanne J Anas; Hitoshi Uemura; Kiyomi Tsuji; Ken-Ichi Harada
Journal:  Mar Drugs       Date:  2018-02-06       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.